Xbrane Biopharma
Invitation to presentation of Xbrane Biopharma’s interim report January – September 2023 on November 30, 2023
Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Thursday, November 30th, 2023, at 11.00 a.m. CET. Xbrane will publish the company’s interim report January – September 2023, on Thursday, November 30, 2023, at 8.00 a.m. CET.
Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – September 2023, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below:
If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
Xbrane Biopharma Q3 Report 2023 (financialhearings.com)
If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
Call Access (financialhearings.com)
Datum | 2023-11-28, kl 07:00 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)